| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Katkin Keith is a Director at Syndax Pharmaceuticals Inc with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 9 sells.
Estimated insider holdings value: $3.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2025 | EBS Emergent Biosolutions Inc. | Director | Sell | 7,844 | $6.30 | $49,417.20 | -8.3% | +45.6% | - | |
| May 19, 2025 | SNDX Syndax Pharmaceuticals Inc | Director | Buy | 10,000 | $9.11 | $91,120.00 | +11.1% | +70.6% | - | |
| Oct 6, 2022 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 29,899 | $25.90 | $774,411.01 | -31.8% | -5.1% | -51.4% | |
| Oct 4, 2022 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 4,101 | $25.06 | $102,776.76 | -2.1% | +2.6% | -51.3% |